Journal of Interventional Cardiology · 2009 · 18 citations · 25 references
MedicineCardiologySurgeryInterventional CardiologyTissue EngineeringVascular SurgeryCoronary AngioplastyCoronary Artery DiseaseCoronary Artery SurgeryEndovascular SurgeryPercutaneous Coronary InterventionStent PlacementBifurcationCoronary Stent DeploymentCoronary StentingElectron Microscopy FindingsEndothelializationScanning Electron Microscopy Surface AnalysisStainless Steel ImplantsStent Apposition Assessment
OBJECTIVE: To evaluate the degree of endothelialization of the nonapposed struts located at the ostia of side branches. BACKGROUND: Endothelialization of coronary stents has got considerable relevance because of the phenomenon of late thrombosis. Bifurcation location and incomplete stent apposition have been linked to this complication. METHODS: Domestic pigs (n = 11; weight: 25 +/- 3 kg) were anesthetized and had one stent per coronary artery implanted: one stainless steel (Tecnic), one cobalt-chromium (Chrono), and one tacrolimus-eluting stent (Janus), all of them being Carbofilm-coated (Sorin). One, three, or seven days postprocedure, the pigs were sacrificed, the hearts explanted, and longitudinal sections examined by surface electron microscopy to quantify the percentage of the strut endothelialized over the branches and in the total surface. RESULTS: Forty-four side branches (25 stents) that had stent struts over their origin were evaluated. Different patterns of endothelialization were observed, from the total absence to the complete endothelialization. There were no significant differences in relation to type of stent or to the artery treated. The predictors of higher percentage of endothelialization were the ratio of metal to branch diameter (P = 0.04) and better endothelialization in the rest of the stent (P = 0.0002), only this parameter maintaining significant correlation (P = 0.03) in multivariate analysis. CONCLUSIONS: Carbofilm-coated stent struts located over the origin of side branches follow the pattern of endothelialization for the rest of the stent, even in the case of tacrolimus-eluting stent.
25
Pathology of Drug-Eluting Stents in Humans
Michael Joner, Aloke V. Finn, Andrew Farb et al. · Journal of the American College of Cardiology · 2006 · 2.7K citations
Medicine, Cardiology, Pathology +11
Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
Gregg W. Stone, Jeffrey W. Moses, Stephen G. Ellis et al. · New England Journal of Medicine · 2007 · 1.6K citations · Full text
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent
Renu Virmani, Giulio Guagliumi, Andrew Farb et al. · Circulation · 2004 · 1.5K citations · Full text
Medicine, Cardiology, Immunology +13